Table of Contents
<< Previous Issue | Oct 2021 (Vol: 2021, Issue: 10) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Acquisition of Antibody Specialist Teneobio for US$2.5 B by Amgen
-
Merck & Co. Gets Sotatercept with US$11.5 B Acceleron Buyout
- Section: Research & Development
-
Janssen Biotech Bolsters Immuno-Oncology Pipeline with Xencor’s Bispecific Antibodies